Zimmer biomet stock - How To Discuss

Zimmer biomet stock

Can Zimmer Biomet sustain or increase its dividend? This suggests that Zimmer Biomet can maintain or increase its dividend. Zimmer Biomet experts have not bought or sold any shares of the company in the past three months. Only a portion of Zimmer Biomet's stock is owned by insiders. Zimmer Biomet's holdings are owned by institutions.

What are Wall Street's price targets for Zimmer Biomet's stock?

19 Wall Street analysts have set 12-month price targets for the shares of Zimmer Biomets. Your forecast varies between $ and $. On average, they expect the stock price of Zimmer Biomets to reach $100 in the next year. This indicates a possible rise in the current share price.

Should you buy orthopedic stocks like Zimmer Biomet (ZBH) in 2022?

With stocks in orthopedic companies like Zimmer Biomet (ZBH) struggling with a host of issues, it makes sense to invest in medical device stocks like TMO, NEOG and CERN in 2022.

What is the earnings release date for zonezimmer Biomet Holdings Inc (ZBH)?

Zimmer Biomet Holdings Inc (NYSE:ZBH) released its earnings report on Friday, July 26. The medical device maker reported dollar earnings per share (EPS) for the quarter, beating Thomson Reuters' consensus estimate of $to$.

What does Zimmer Biomet Holdings'upcoming dividend look like?

The company's next dividend is $0.24 per share after the last 12 months when the company paid a total of $0. 96 per share for shareholders. Total dividend payments for last year show that Zimmer Biomet Holdings returned 0.8% at its current share price of $122.46

What does zonezimmer Biomet Holdings do?

Zimmer Biomet Holdings, Inc. provides services for the treatment of the musculoskeletal system. It operates in the following segments: Americas and the World, EMEA and Asia-Pacific.

What does Zimmer Biomet's PE ratio and PEG ratio indicate?

Zimmer Biomet's P/E ratio is , which means that the company trades at a higher P/E ratio than the market's average P/E, which is roughly equivalent to Zimmer's P/E ratio. Biomet, meaning it's at a higher price/profit multiple. E ratio as the average P/E ratio in the medical industry, roughly equivalent to Zimmer Biomet, has a PEG ratio

How has Zimmer Biomet’s shares performed in 2021?

Shares of Zimmer Biomet ZBH have been extremely weak so far in 2021, in line with the declining volume trend in the orthopedic industry as a whole.

Should you avoid orthopedic stocks like Zimmer Biomet (Zimmer) now?

Since a significant portion of the orthopedic field is non-essential and operations have been delayed, negative business impacts are also expected in the coming months. In such a scenario, they ask investors to avoid orthopedic stocks like Zimmer Biomet, rated Zacks #4 (sell).

What are the best stocks to buy in 2022?

Two blue chip stocks, cheap growth stocks, growth stocks with upside potential and the COVID-19 pandemic make up a list of five stocks to buy for 2022.

Is Zimmer Biomet Holdings (ZBH) a buy at $170?

Needham analyst Michael Matson gave Zimmer Biomet Holdings (ZBH) a buy recommendation today with a price target of $170.

What is the old name of Zimmer Biomet?

Formerly known as Zimmer Holdings, Inc, the company changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Where is zonezimmer Biomet located?

Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana. More information Unfortunately, this data cannot be displayed at this time. End of interactive diagram.

Is Zimmer Biomet's PE ratio overvalued or undervalued?

Zimmer Biomet's P/E ratio is , meaning it trades at a higher P/E ratio than the average P/E ratio of the medical industry around Zimmer Biomet. A PEG ratio greater than 1 indicates that the company may be overvalued. Zimmer Biomet has a P/B ratio

Zimmer biomet stock dividend history

Dividend History Summary Zimmer Biomet (ZBH) announced on November 16, 2021 that shareholders who received a dividend of $ per share on December 27, 2021 would receive a dividend of $ per share on January 31, 2022. ZBH currently pays investors $ per share or more per share per year.

What does Zimmer Biomet do?

Its products and solutions help treat patients with diseases or injuries of bones, joints or soft tissues. Zimmer Biomet Holdings was founded in 1927 by Justin O. Zimmer and is headquartered in Warsaw, Indiana.

Is Zimmer Biomet's persona knee system better than Stryker's Mako?

While the Zimmers Persona Knee System allows for additional customization, it also means additional complexity in inventory management (with no apparent clinical benefits). Zimmer Biomet is still catching up with its Rosa robot and probably won't be able to match the installed base of Stryker Mako robots anytime soon.

Who is the founder of Zimmer brands?

The company was founded in 1927 by Justin O. Zimmer and is headquartered in Warsaw, Indiana.

Is Zimmer Biomet's PE ratio too expensive?

Zimmer Biomet's earnings are expected to grow from $ to $ a share next year. Zimmer Biomet's P/E is , meaning the company trades at a higher P/E than the market average P/E of approximately

Who buys Zimmer Biomet Holdings Inc?

Mrj Capital Inc buys Zimmer Biomet Holdings Inc, Raytheon Technologies Corp, sells Zimmer Biomet Holdings, Inc, which provides musculoskeletal treatment services. It operates in the following segments: Americas and the World, EMEA and Asia-Pacific.

What does zonezimmer Biomet do?

Zimmer Biomet Holdings Inc. designs, manufactures and markets products for orthopedic reconstruction, sports medicine products, extremity and trauma products, craniomaxillofacial and thoracic products, dental implants and related surgical products. The company operates in three geographic segments: Americas, Europe and Asia-Pacific.